Title : Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy.

Pub. Date : 2014 Mar 20

PMID : 24415539






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The Bruton"s tyrosine kinase (BTK) inhibitor ibrutinib has outstanding activity in patients with chronic lymphocytic leukemia. ibrutinib Bruton tyrosine kinase Homo sapiens
2 The Bruton"s tyrosine kinase (BTK) inhibitor ibrutinib has outstanding activity in patients with chronic lymphocytic leukemia. ibrutinib Bruton tyrosine kinase Homo sapiens